New evidence of heterogeneity in social anxiety disorder: Defining two qualitatively different personality profiles taking into account clinical, environmental and genetic factors

European Psychiatry

Volumn 30, Issue 1, 2015, Pages 160-165

  Binelli, C ^a,b   Muniz A ^a,c   Sanches, S ^a,d   Ortiz, A ^a,c   Navines, R ^a,e   Egmond, E ^a,b   Udina, M ^a   Batalla, A ^a,c   Lopez Sola C ^b   Crippa, J A ^d   Subira S ^b   Martin Santos R ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e HOSPITAL DEL MAR   (Spain)

Author keywords

Harm avoidance; Impulsive subtype; Novelty seeking; Social anxiety disorder; Temperament and character inventory, STin2.VNTR

Indexed keywords

SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; HEREDITY; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; NOVELTY SEEKING; PERSONALITY ASSESSMENT; PRIORITY JOURNAL; SENSATION SEEKING; SOCIAL PHOBIA; SUBSTANCE USE; SUICIDE ATTEMPT; TEMPERAMENT; UNIVERSITY STUDENT; ADOLESCENT; EXPLORATORY BEHAVIOR; GENETIC POLYMORPHISM; GENETICS; PERSONALITY; PERSONALITY DISORDER; PHOBIA; PSYCHOLOGY; SOCIAL ENVIRONMENT;

ADOLESCENT; ADULT; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HUMANS; MALE; PERSONALITY; PERSONALITY DISORDERS; PHOBIC DISORDERS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SOCIAL ENVIRONMENT;

EID: 84920989012     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2014.09.418     Document Type: Article

References (53)

1. Kessler R.C., Petukhova M., Sampson N.A., Zaslavsky A.M., Wittchen H.-U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012, 21(3):169-184.
2. Diagnostic A.P.A. Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. 4th ed.
3. Filho A.S., Hetem L.A.B., Ferrari M.C.F., Trzesniak C., Martín-Santos R., Borduqui T., et al. Social anxiety disorder: what are we losing with the current diagnostic criteria?. Acta Psychiatr Scand 2010, 121(3):216-226.
4. Marteinsdottir I., Svensson A., Svedberg M., Anderberg U.M., von Knorring L. The role of life events in social phobia. Nord J Psychiatry 2007, 61(3):207-212.
5. Stein M., Stein D. Seminar Social anxiety disorder. Lancet 2008, 371:1115-1125.
6. Kampman O., Viikki M., Järventausta K., Leinonen E. Meta-analysis of anxiety disorders and temperament. Neuropsychobiology 2014, 69(3):175-186.
7. Grant B., Hasin D., Blanco C., Stinson F., Chou S., Goldstein R., et al. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005, 66(11):1351-1361.
8. Cloninger C., Svrakic D., Przybeck T. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993, 50(12):975-990.
9. Cloninger C. A systematic method for clinical description and classification of personality variants: A proposal. Arch Gen Psychiatry 1987, 44(6):573-588.
10. Chatterjee S., Sunitha T., Velayudhan A., Khanna S. An investigation into the psychobiology of social phobia: personality domains and serotonergic function. Acta Psychiatr Scand 1997, 95(6):544-550.
11. Pélissolo a, André C., Pujol H., Yao S.N., Servant D., Braconnier A., et al. Personality dimensions in social phobics with or without depression. Acta Psychiatr Scand. 2002, 105(2):94-103.
12. Hofmann S.G., Loh R. The Tridimensional Personality Questionnaire: changes during psychological treatment of social phobia. J Psychiatr Res 2006, 40(3):214-220.
13. Marteinsdottir I., Tillfors M., Furmark T., Anderberg U.M., Ekselius L. Personality dimensions measured by the Temperament and Character Inventory (TCI) in subjects with social phobia. Nord J Psychiatry 2003, 57(1):29-35.
14. Birbaumer N., Grodd W., Diedrich O., Klose U., Erb M., Lotze M., et al. fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 1998, 9(6):1223-1226.
15. Faytout M., Tignol J., Swendsen J., Grabot D., Aouizerate B., Lépine J.P. Social phobia, fear of negative evaluation and harm avoidance. Eur Psychiatry 2007, 22(2):75-79.
16. Lochner C., Hemmings S., Seedat S., Kinnear C., Schoeman R., Annerbrink K., et al. Genetics and personality traits in patients with social anxiety disorder: a case control study in South Africa. Eur Neuropsychopharmacol 2007, 17(5):321-327.
17. Mörtberg E., Bejerot S., Aberg Wistedt A. Temperament and character dimensions in patients with social phobia: patterns of change following treatments?. Psychiatry Res 2007, 152(1):81-90.
18. Kachin K.E., Newman M.G., Pincus A.L. An interpersonal problem approach to the division of social phobia subtypes. Behav Ther 2001, 32(3):479-501.
19. Kashdan T.B., Hofmann S.G. The high-novelty-seeking, impulsive subtype of generalized social anxiety disorder. Depress Anxiety 2008, 25(6):535-541.
20. Kashdan T.B., McKnight P.E., Richey J.A., Hofmann S.G. When social anxiety disorder co-exists with risk-prone, approach behavior: investigating a neglected, meaningful subset of people in the National Comorbidity Survey-Replication. Behav Res Ther 2009, 47(7):559-568.
21. Kashdan T.B., Elhai J.D., Breen W.E. Social anxiety and disinhibition: an analysis of curiosity and social rank appraisals, approach-avoidance conflicts, and disruptive risk-taking behavior. J Anxiety Disord 2008, 22(6):925-939.
22. Mörtberg E., Tillfors M., van Zalk N., Kerr M. An atypical anxious-impulsive pattern of social anxiety disorder in an adult clinical population. Scand J Psychol 2014, 55(4):350-356.
23. Miskovic V., Schmidt L.A. Social fearfulness in the human brain. Neurosci Biobehav Rev 2012, 36(1):459-478.
24. Savitz J.B., Ramesar R.S. Genetic variants implicated in personality: a review of the more promising candidates. Am J Med Genet Part B 2004, 131B(1):20-32.
25. Serretti A., Calati R., Mandelli L., De Ronchi D. Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets 2006, 7(12):1659-1669.
26. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66(6):2621-2624.
27. Fiskerstrand C.E., Lovejoy E.A., Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele-dependent differential enhancer activity in embryonic stem cells. FEBS Lett 2014, 458(2):171-174.
28. MacKenzie A., Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci 1999, 96(26):15251-15255.
29. Furmark T., Tillfors M., Garpenstrand H., Marteinsdottir I., Långström B., Oreland L., et al. Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 2004, 362(3):189-192.
30. Furmark T., Henningsson S., Appel L., Ahs F., Linnman C., Pissiota A., et al. Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. J Psychiatry Neurosci 2009, 34(1):30-40.
31. Klumpp H., Fitzgerald D.A., Cook E., Shankman S.A., Angstadt M., Phan K.L. Serotonin transporter gene alters insula activity to threat in social anxiety disorder. Neuroreport 2014, 25(12):926-931.
32. Rytwinski N.K., Fresco D.M., Heimberg R.G., Coles M.E., Liebowitz M.R., Cissell S., et al. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale. Depress Anxiety 2009, 26(1):34-38.
33. Liebowitz M. Social phobia. Mod Prob Pharmacopsychiatry 1987, 22:141-173.
34. Bobes J., Badía X., Luque A., García M., González M., Dal-Ré R. Validación de las versiones en español de los cuestionarios Liebowitz Social Anxiety Scale. Social Anxiety and Distres Scale y Sheehan Disability Inventory para la evaluación de la fobia social. Med Clin 1999, 112(14):14-16.
35. First M.B., Spitzer R.L., Gibbon M.W.J. Structured Clinical Interview for DSM-IV-RS Axis 1 Disorders 2007, Biometrics, New York.
36. Gutiérrez F., Torrens N., Boget T., Martín-Santos R., Sangorrín J., Pérez G., et al. Psychometric properties of the Temperament and Character Inventory (TCI) questionnaire in a Spanish psychiatric population. Acta Psychiatr Scand 2001, 103(2):143-147.
37. Svrakic D.M., Draganic S., Hill K., Bayon C., Przybeck T.R., Cloninger C.R. Temperament, character, and personality disorders: etiologic, diagnostic, treatment issues. Acta Psychiatr Scand 2002, 106(3):189-195.
38. Stevens S., Cludius B., Bantin T., Hermann C., Gerlach A.L. Influence of alcohol on social anxiety: an investigation of attentional, physiological and behavioral effects. Biol Psychol 2014, 96(0):126-133.
39. Csorba J., Dinya E., Ferencz E., Steiner P., Bertalan G., Zsadon A. Novelty seeking: difference between suicidal and non-suicidal Hungarian adolescent outpatients suffering from depression. J Affect Disord 2014, 120(1):217-220.
40. Krysinska K., Heller T.S., De Leo D. Suicide and deliberate self-harm in personality disorders. Curr Opin Psychiatry 2006, 19(1):95-101.
41. Gutiérrez F., Navinés R., Navarro P., García-Esteve L., Subirá S., Torrens M., et al. What do all personality disorders have in common? Ineffectiveness and uncooperativeness. Compr Psychiatry 2008, 49(6):570-578.
42. Erwin B., Heimberg R., Liebowitz M., Schneir F. Anger experience and expression in social anxiety disorder: pretreatment profile and predictors of attrition and response to cognitive-behavioral treatment. Behav Ther 2003, 34(3):331-350.
43. Kazantseva A.V., Gaysina D.A., Faskhutdinova G.G., Noskova T., Malykh S.B., Khusnutdinova E.K. Polymorphisms of the serotonin transporter gene (5-HTTLPR, A/G SNP in 5-HTTLPR, and STin2 VNTR) and their relation to personality traits in healthy individuals from Russia. Psychiatr Genet 2008, 18(4):167-176.
44. Ohara K., Suzuki Y., Ochiai M., Tan K., Ohara K., Tsukamoto T., et al. A variable number tandem repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry 1999, 23(1):55-65.
45. Baca-Garcia E., Vaquero-Lorenzo C., Diaz-Hernandez M., Rodriguez-Salgado B., Dolengevich-Segal H., Arrojo-Romero M., et al. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(2):416-420.
46. Rees M., Norton N., Jones I., McCandless F., Scourfield J., Holmans P., et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 1995, 2(7):398-402.
47. Fan J.B., Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 2005, 10(10):928-938. [891].
48. Florez G., Saiz P., Garcia-Portilla P., Alvarez S., Nogueíras L., Morales B., et al. Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients. Alcohol Alcohol 2008, 43(5):516-522.
49. Pizzo de Castro M., Maes M., Guembarovski R., Ariza C., Reiche E.M., Vargas H., et al. SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study. BMC Genet 2014, 15(1):78.
50. Bah J., Lindström M., Westberg L., Mannerås L., Ryding E., Henningsson S., et al. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res Neuroimaging 2014, 162(3):221-229.
51. Kluger a N., Siegfried Z., Ebstein R.P. A meta-analysis of the association between DRD4 polymorphism and novelty seeking. Mol Psychiatry 2002, 7(7):712-717.
52. Kyeong S., Kim E., Park H.-J., Hwang D.-U. Functional network organizations of two contrasting temperament groups in dimensions of novelty seeking and harm avoidance. Brain Res 2014, 1575:33-44.
53. Adolphs R. The biology of fear review. Curr Biol 2013, 23(2):R79-R93.